Saxenda in Canada: liraglutide for weight management

Saxenda at a glance

A prescription liraglutide product authorized for chronic weight management in adults and adolescents who meet the current monograph criteria.^[1]

Saxenda is the liraglutide weight-management product

Saxenda and Victoza contain liraglutide, but their indications differ. The liraglutide ingredient guide keeps the weight-management and diabetes products separate.

Daily administration is a practical difference from weekly products, but frequency alone cannot determine suitability. Product-specific instructions and the clinical context come first.^[1][2]

Age and monograph criteria shape the assessment

A weight-management assessment should connect the current monograph criteria with health history, previous approaches, current medicines, contraindications, expectations and follow-up. Adolescents require age-appropriate clinical care; this page is not a dosing guide.

Daily use and a marketed DIN answer different questions

Health Canada’s DPD listed Saxenda DIN 02437899 as Marketed when checked August 14, 2026. Marketed means the DIN is active and the product is currently sold in Canada; it does not promise stock at a particular pharmacy.

Daily administration may affect practical fit, while current price and plan payment require the exact-DIN checks in the cost guide and coverage guide.^[2][3]